Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Active
CMS-1865-N

CMS-1865-N FY 2028 New Technology Add-On Payment Town Hall and Public Comment Opportunity

CMS Notice CMS-1865-N opens the FY 2028 New Technology Add-On Payment Town Hall and public comment process. Presenter registration is due November 2, 2026 at 5:00 p.m. ET; presentation materials are due November 12 at 5:00 p.m. ET; written SCI comments are due December 14 at 5:00 p.m. ET.

FundingNot a funding opportunity. No award amount or applicant cap.
DeadlinePresenter registration: November 2, 2026 at 5:00 p.m. ET. Presentation materials and written remarks: November 12, 2026 at 5:00 p.m. ET. Virtual Town Hall: December 9, 2026, and December 10 if needed, beginning at 9:00 a.m. EST. Written SCI comments: December 14, 2026 at 5:00 p.m. EST.
Last verifiedSeptember 17, 2026
Required next actionMonitor CMS for the FY 2028 pending-application list, final Town Hall agenda, and any technology-specific relevance before considering participation. Do not infer a Dr. Miltie or N9+ presentation path from this notice alone.

Broad Eligibility

Public NTAP Town Hall/comment process. Hospitals, physicians, manufacturers, and other interested parties may present or submit evidence regarding whether pending FY 2028 NTAP applications meet the substantial clinical improvement criterion.

Atlas Analysis

High-value federal Medicare payment-policy intelligence for inpatient new technologies. This is a public participation process, not a grant or procurement award. No direct Dr. Miltie or N9+ participation path is established; product-specific relevance depends on the actual FY 2028 pending NTAP applications and evidence tied to the substantial clinical improvement criterion.

Federal Medicare Payment Policy Opportunity — Not a Grant

The Centers for Medicare & Medicaid Services (CMS) has issued CMS-1865-N, announcing the FY 2028 New Technology Town Hall for applications seeking New Technology Add-On Payments (NTAP) under the hospital Inpatient Prospective Payment System. The public process is focused on whether FY 2028 NTAP applications meet the substantial clinical improvement criterion.

Key Dates

  • Presenter registration: November 2, 2026 at 5:00 p.m. Eastern Time.
  • Presentation slide decks, agenda items, written remarks, and special-accommodation requests: November 12, 2026 at 5:00 p.m. Eastern Time.
  • Virtual Town Hall: December 9, 2026, beginning at 9:00 a.m. EST, with December 10 used if a second day is needed.
  • Post-meeting written comments on substantial clinical improvement: December 14, 2026 at 5:00 p.m. EST.

Participation

Organizations representing hospitals, physicians, manufacturers, and other interested parties may present comments, recommendations, and data. Presenter registration and written materials are submitted to NTAP@cms.hhs.gov. Registration is not required for people who only attend. CMS states that comments should be limited to information relevant to whether the pending NTAP application or applications meet the substantial clinical improvement criterion.

Atlas Relevance

This is a Medicare coding and payment-policy participation opportunity, not a grant, procurement award, or guaranteed payment pathway. It is relevant to hospitals, manufacturers, clinical innovators, and other stakeholders following inpatient new-technology reimbursement. A product-specific submission should be considered only when the technology is actually part of a pending FY 2028 NTAP application and the commenter has evidence directly relevant to the substantial clinical improvement criterion.

No direct Dr. Miltie or N9+ participation path is established by this notice. Prior NTAP eligibility screening should not be overridden by the Town Hall notice alone.

Official CMS source: CMS New Medical Services and New Technologies

Federal Register notice: CMS-1865-N

Source verificationOfficial government source · www.cms.govAtlas last verified this record September 17, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗